review
remark
author
author
present
antigen
character
method
base
structur
inform
claim
first
algorithm
gener
protein
antigen
structur
inform
use
epitop
comparison
probabl
structur
inform
alon
suffici
defin
antigen
distanc
due
challeng
structur
model
well
known
result
structur
model
singl
mutat
eg
model
without
detail
difficult
believ
structur
inform
alon
use
influenza
antigen
measur
singl
mutat
lead
antigen
drift
addit
within
singl
antigen
drift
event
uncommon
mutat
occur
one
epitop
current
method
seem
target
singl
epitop
seem
realist
influenza
studi
use
critic
author
illustr
chang
epitop
fingerprint
past
four
decad
result
match
antigen
drift
event
well
character
author
claim
collect
hi
data
variou
sourc
data
long
list
sourc
supplementari
note
clear
mani
hi
tabl
actual
includ
data
integr
analys
know
hi
data
list
sourc
perform
differ
time
differ
lab
differ
protocol
especi
differ
red
blood
cell
thu
difficult
believ
valid
result
use
dataset
meaning
dataset
shall
provid
avail
user
even
author
claim
broadli
protect
experiment
result
suggest
high
cross
activ
one
test
strain
other
author
enclos
sequenc
know
detail
seem
sequenc
could
design
particular
strain
addit
common
use
mice
character
influenza
antigen
mani
public
relat
epitop
comparison
use
structur
would
suggest
author
review
literatur
discuss
limit
current
studi
improv
would
suggest
author
focu
influenza
virus
mani
statement
manuscript
either
overst
confus
exampl
first
statement
summari
statement
confus
review
remark
author
manuscript
qiu
et
al
develop
novel
comput
method
ceblast
evalu
antigen
similar
mutat
antigen
base
local
structur
physicochem
featur
conform
epitop
method
present
good
perform
two
independ
test
dataset
impress
design
rel
broadspectrum
vaccin
strain
influenza
method
found
predict
agre
well
experiment
result
howev
detail
evid
need
support
method
conclus
author
claim
ceblast
could
compar
antigen
similar
protein
antigen
gener
protein
antigen
look
like
method
suitabl
mutat
antigen
one
domin
conform
epitop
gener
protein
antigen
pair
one
protein
antigen
may
one
epitop
method
use
evalu
antigen
similar
two
protein
potenti
epitop
pair
need
compar
summar
thu
author
could
point
usag
condit
boundari
method
clearli
scarciti
immun
crossreact
data
sequenc
similar
variabl
v
region
antibodi
use
measur
antigen
similar
howev
author
present
evid
reason
use
vregion
could
author
show
high
correl
sequenc
similar
variabl
v
region
antibodi
antigen
variat
antigen
influenza
ha
protein
sever
paramet
ceblast
algorithm
formula
curiou
paramet
determin
train
dataset
accord
descript
two
class
featur
use
algorithm
includ
local
structur
physicochem
fingerprint
perform
final
model
test
shown
manuscript
contribut
featur
shown
solid
could
better
test
contribut
featur
show
neces
method
key
idea
ceblast
algorithm
predict
antigen
similar
variat
base
conform
structur
physicochem
fingerprint
far
know
method
eadpr
publish
paper
name
correl
influenza
viru
excess
mortal
antigen
variat
applic
rapid
estim
influenza
mortal
burden
similar
idea
better
discuss
similar
differ
algorithm
method
pleas
provid
detail
design
ha
sequenc
con
sequenc
antigen
site
con
comparison
con
seven
refer
strain
also
better
analyz
discuss
molecular
mechan
crossreact
con
strain
review
remark
author
paper
present
method
call
ceblast
compar
antigen
similar
protein
antigen
method
interest
novel
involv
spinimag
shell
structur
model
paper
gener
well
written
key
issu
evalu
ceblast
perform
one
evalu
conduct
use
sequenc
similar
variabl
v
region
correspond
antibodi
measur
antigen
similar
epitop
word
known
epitop
assay
selfevid
sequenc
similar
variabl
region
well
correl
antigen
similar
respect
epitop
realli
need
establish
inde
must
mani
contrari
exampl
eg
singl
mutat
lead
antigen
escap
noncontact
residu
variabl
region
neglig
impact
antigen
substitut
differ
antibodi
bind
moreorless
epitop
use
differ
bind
mode
potenti
complic
need
address
well
implic
robust
valid
structur
inform
use
epitop
comparison
probabl
structur
inform
alon
suffici
defin
antigen
distanc
due
challeng
structur
model
well
known
result
structur
model
singl
mutat
eg
model
without
detail
difficult
believ
structur
inform
alon
use
influenza
antigen
measur
singl
mutat
lead
antigen
drift
addit
within
singl
antigen
drift
event
uncommon
mutat
occur
one
epitop
current
method
seem
target
singl
epitop
seem
realist
influenza
studi
thank
point
ye
agre
structur
inform
alon
may
suffici
enough
ceblast
seri
physicchem
fingerprint
besid
structur
inform
ad
complement
evalu
antigen
distanc
incorpor
addit
inform
explor
futur
version
ceblast
meanwhil
test
potenti
influenc
antigen
distanc
model
structur
compar
crystal
structur
take
ha
exampl
found
classif
result
show
full
agreement
model
structur
experiment
one
indic
feasibl
ceblast
model
protein
structur
detail
result
illustr
total
ha
crystal
structur
group
c
pdb
collect
avail
ha
sequenc
dataset
correspond
model
structur
group
obtain
follow
protocol
studi
b
pairwis
antigen
distanc
calcul
via
ceblast
use
default
paramet
structur
within
group
c
within
group
intragroup
distanc
group
g
group
intergroup
distanc
respect
result
found
figur
seen
classif
result
show
agreement
crystalizedmodel
structur
modeledmodel
structur
indic
use
model
structur
show
littl
influenc
ceblast
result
figur
comparison
antigen
distanc
inter
intra
group
line
repres
model
ha
structur
column
repres
crystal
structur
line
column
repres
model
ha
structur
line
column
repres
crystal
structur
color
grid
refer
predict
antigen
distanc
correspond
pair
blue
indic
antigen
similar
pair
predict
antigen
distanc
green
yellow
repres
antigen
variant
predict
antigen
distanc
true
ceblast
suitabl
mutat
antigen
one
domin
epitop
howev
case
ha
antigen
whole
neighbor
area
site
actual
taken
account
cover
full
length
residu
default
paramet
sens
ceblast
detect
antigen
distanc
caus
mutat
whole
protein
paper
take
site
calcul
fingerprint
instead
full
length
differ
contribut
antigen
varianc
meanwhil
select
repres
site
calcul
fingerprint
significantli
reduc
comput
load
use
critic
author
illustr
chang
epitop
fingerprint
past
four
decad
result
match
antigen
drift
event
well
character
great
question
suggest
calcul
distinct
antigen
cluster
past
year
base
sequenc
ad
result
part
page
evalu
whether
fingerprintbas
algorithm
predict
wellknown
antigen
cluster
past
four
decad
firstli
calcul
antigen
distanc
strain
year
domin
strain
previou
year
accord
chronolog
order
defin
new
antigen
cluster
antigen
coverag
new
antigen
variant
within
current
year
substanti
larg
compar
domin
strain
previou
year
domin
strain
first
year
set
ahong
domin
strain
follow
year
identifi
either
one
largest
antigen
coverag
within
year
antigen
variant
emerg
antigen
variant
largest
antigen
coverag
year
detail
found
method
part
ceblast
base
antigen
cluster
algorithm
ceblast
use
construct
antigen
map
histor
ha
protein
determin
antigen
cluster
influenza
fig
differ
antigen
cluster
mark
differ
colour
illustr
antigen
distanc
yaxi
meaning
neighbour
cluster
yaxi
illustr
antigen
distanc
predict
ceblast
spot
repres
domin
strain
year
size
proport
logarithm
number
strain
collect
year
antigen
similar
year
group
antigen
cluster
repres
first
domin
strain
begin
year
cluster
cluster
repres
strain
within
cluster
antigen
distanc
calcul
domin
strain
year
cluster
repres
strain
antigen
distanc
two
neighbour
cluster
calcul
base
repres
strain
seen
past
year
antigen
drift
event
suggest
fingerprint
result
agre
well
wellknown
experiment
studi
smith
silico
predict
du
year
antigen
group
experiment
determin
viral
isol
smith
work
name
first
vaccin
strain
result
repres
vaccin
strain
classifi
distinct
cluster
addit
addit
antigen
group
repres
detect
method
although
experiment
screen
nt
detect
cluster
du
studi
largescal
antigen
map
point
exist
du
model
predict
antigen
cluster
base
ha
sequenc
year
mostli
china
cdc
suggest
cluster
compar
result
cluster
roughli
consist
accord
time
period
two
cluster
group
one
ceblast
high
concord
two
larg
scale
insilico
work
may
impli
typic
epitom
china
global
profil
also
ad
new
paragraph
ceblast
base
antigen
cluster
algorithm
onlin
method
part
follow
page
year
n
strain
collect
antigen
distanc
firstli
calcul
binari
strain
pair
antigen
coverag
strain
x
defin
repres
number
antigen
similar
pair
antigen
distanc
strain
x
within
year
first
year
set
domin
strain
next
year
strain
drift
strain
antigen
distanc
simultan
suffici
larg
antigen
popul
year
author
claim
collect
hi
data
variou
sourc
data
long
list
sourc
supplementari
note
clear
mani
hi
tabl
actual
includ
data
integr
analys
know
hi
data
list
sourc
perform
differ
time
differ
lab
differ
protocol
especi
differ
red
blood
cell
thu
difficult
believ
valid
result
use
dataset
meaning
dataset
shall
provid
avail
user
agre
hi
data
differ
sourc
may
show
differ
result
despit
hi
assay
wide
use
assess
antigen
similar
influenza
virus
mayb
nt
make
clear
normal
experiment
distanc
done
follow
reduc
data
nois
check
strain
pair
dataset
pair
found
contradict
antigen
classif
differ
experi
tabl
final
classif
determin
step
shown
tabl
revis
version
hi
tabl
use
studi
revis
method
normal
hi
tabl
provid
supplementari
note
tabl
strain
pair
differ
antigen
relationship
differ
assay
first
two
column
repres
two
strain
pair
hi
assay
follow
three
column
repres
number
experiment
record
differ
antigen
relationship
even
author
claim
broadli
protect
experiment
result
suggest
high
cross
activ
one
test
strain
other
author
enclos
sequenc
know
detail
seem
sequenc
could
design
particular
strain
addit
common
use
mice
character
influenza
antigen
manuscript
main
purpos
con
case
design
illustr
use
ceblast
facilit
futur
vaccin
design
valid
experiment
result
fulli
agre
predict
result
although
rel
lower
titer
compar
group
titer
strain
fairli
strong
compar
control
group
addit
antibodi
bind
assay
figur
show
crossact
strain
sequenc
con
design
collect
strain
sequenc
con
given
follow
although
ferret
frequent
use
assess
influenza
antigen
number
report
recent
adopt
mice
evalu
vaccin
immunogen
efficaci
mice
model
much
costeffect
readili
avail
addit
mice
capabl
mount
vigor
humor
tcell
immun
respons
mani
public
relat
epitop
comparison
use
structur
would
suggest
author
review
literatur
discuss
limit
current
studi
improv
thank
point
current
sever
method
publish
epitop
comparison
use
structur
compar
three
avail
method
epitopematch
eadpr
predac
ad
paragraph
discuss
part
revis
manuscript
page
addit
structur
comparison
method
relat
epitop
comparison
use
structur
epitopematch
eadpr
predac
epitopematch
firstli
develop
superimpos
structur
epitop
deriv
rmsd
base
atom
coordin
atom
type
without
consider
physicchem
properti
amino
acid
jiang
group
design
machin
learn
method
eadpr
via
compar
averag
differ
epitop
area
base
individu
physicchem
properti
ha
residu
idea
expand
preadac
antigen
cluster
incorpor
structur
distanc
receptor
bind
region
paper
ceblast
take
full
account
potenti
influenc
residu
layout
local
microenviron
caus
structur
variat
residu
mutat
would
suggest
author
focu
influenza
virus
mani
statement
manuscript
either
overst
confus
exampl
first
statement
summari
statement
confus
confus
statement
correct
version
revis
summari
paragraph
discuss
part
follow
page
conclus
design
gener
algorithm
abl
compar
antigen
similar
differ
conform
epitop
protein
antigen
use
ceblast
shown
influenza
virus
vast
accumul
ha
mutant
data
type
mutat
antigen
also
feasibl
epitop
posit
defin
subsequ
improv
elabor
addit
paramet
parallel
comput
increas
comput
effici
futur
updat
epitop
databas
cover
hiv
tumor
antigen
ceblast
may
becom
use
facilit
antigen
map
potenti
vaccin
develop
wide
rang
diseas
review
remark
author
manuscript
qiu
et
al
develop
novel
comput
method
ceblast
evalu
antigen
similar
mutat
antigen
base
local
structur
physicochem
featur
conform
epitop
method
present
good
perform
two
independ
test
dataset
impress
design
rel
broadspectrum
vaccin
strain
influenza
method
found
predict
agre
well
experiment
result
howev
detail
evid
need
support
method
conclus
author
claim
ceblast
could
compar
antigen
similar
protein
antigen
gener
protein
antigen
look
like
method
suitabl
mutat
antigen
one
domin
conform
epitop
gener
protein
antigen
pair
one
protein
antigen
may
one
epitop
method
use
evalu
antigen
similar
two
protein
potenti
epitop
pair
need
compar
summar
thu
author
could
point
usag
condit
boundari
method
clearli
ye
right
theoret
ceblast
design
compar
two
piec
conform
epitop
matter
protein
famili
fact
suitabl
mutat
antigen
similar
score
high
enough
indic
antigen
similar
protein
antigen
one
epitop
potenti
epitop
pair
need
compar
summar
order
evalu
antigen
similar
two
protein
ad
statement
discuss
part
page
scarciti
immun
crossreact
data
sequenc
similar
variabl
v
region
antibodi
use
measur
antigen
similar
howev
author
present
evid
reason
use
vregion
could
author
show
high
correl
sequenc
similar
variabl
v
region
antibodi
antigen
variat
antigen
influenza
ha
protein
smart
question
antigen
without
immun
crossreact
data
similar
correspond
antibodi
vregion
need
check
measur
antigen
similar
ad
part
result
page
check
qualif
measur
antigen
similar
sequenc
similar
variabl
v
region
antibodi
examin
correl
varianc
epitop
composit
lysozym
chosen
exampl
test
sinc
largest
protein
famili
dataset
total
lysozymeantibodi
complex
pdb
size
lysozym
epitop
averag
residu
pearson
correl
coeffici
epitop
composit
differ
vregion
similar
correspond
antibodi
reach
ident
literatur
record
antibodi
deriv
differ
immun
host
mu
complex
camelu
complex
homo
sapien
complex
other
consid
vsequenc
bia
differ
immun
host
take
complex
mice
examin
correl
increas
antibodi
posit
similar
antibodi
ident
similar
shown
supplementari
figur
high
correl
suggest
feasibl
use
vregion
sequenc
similar
antibodi
measur
antigen
similar
howev
also
note
conform
epitop
lysozym
may
induc
quit
differ
sequenc
vregion
antibodi
differ
immun
host
instanc
sequenc
identifi
score
vregion
human
antibodi
mice
antibodi
ident
lysozym
epitop
seem
indic
meaning
adopt
vregion
sequenc
similar
antibodi
measur
antigen
similar
case
immun
host
red
scatter
diagram
repres
vregion
similar
posit
blue
scatter
diagram
repres
vregion
similar
ident
sever
paramet
ceblast
algorithm
formula
curiou
paramet
determin
train
dataset
raw
score
determin
rs
ab
rp
ab
es
ab
rt
ab
formula
rp
ab
indic
residu
pair
rt
ab
indic
residu
translat
score
real
number
contrast
es
ab
repres
accumul
pearson
correl
coeffici
rang
make
three
valu
level
magnitud
order
arbitrarili
set
set
accord
descript
two
class
featur
use
algorithm
includ
local
structur
physicochem
fingerprint
perform
final
model
test
shown
manuscript
contribut
featur
shown
solid
could
better
test
contribut
featur
show
necess
method
good
question
test
contribut
featur
differ
protein
famili
lysozym
complex
complex
seen
tabl
contribut
featur
actual
vari
accord
differ
protein
famili
nevertheless
combin
featur
alway
give
best
perform
thu
use
combin
featur
model
mean
vregion
similar
set
ident
c
combin
mean
structur
fingerprint
combin
physicalchem
fingerprint
gener
physicalchem
mean
combin
three
physicalchem
properti
key
idea
ceblast
algorithm
predict
antigen
similar
variat
base
conform
structur
physicochem
fingerprint
far
know
method
eadpr
publish
paper
name
correl
influenza
viru
excess
mortal
antigen
variat
applic
rapid
estim
influenza
mortal
burden
similar
idea
better
discuss
similar
differ
algorithm
method
thank
remind
ad
one
paragraph
discuss
part
revis
manuscript
follow
page
addit
structur
comparison
method
relat
epitop
comparison
use
structur
epitopematch
eadpr
predac
epitopematch
firstli
develop
superimpos
structur
epitop
deriv
rmsd
base
atom
coordin
atom
type
without
consider
physicchem
properti
amino
acid
jiang
group
design
machin
learn
method
eadpr
via
compar
averag
differ
epitop
area
base
individu
physicchem
properti
ha
residu
idea
expand
preadac
antigen
cluster
incorpor
structur
distanc
receptor
bind
region
paper
ceblast
take
full
account
potenti
influenc
residu
layout
local
microenviron
caus
structur
variat
residu
mutat
pleas
provid
detail
design
ha
sequenc
con
sequenc
antigen
site
con
comparison
con
seven
refer
strain
also
better
analyz
discuss
molecular
mechan
crossreact
con
strain
suggest
provid
con
sequenc
compar
seven
refer
strain
ad
follow
paragraph
section
result
page
say
compar
sequenc
con
seven
refer
strain
result
show
supplementari
figur
compar
con
identifi
two
mutat
sequenc
one
posit
within
antigen
site
contain
seven
mutat
also
one
antigen
site
similarli
possess
mutat
two
antigen
site
interestingli
least
mutat
identifi
antigen
vari
strain
may
explain
differ
crossreact
among
supplementari
figur
sequenc
comparison
con
seven
refer
strain
mutat
refer
strain
compar
con
shadow
differ
color
antigen
site
use
ceblast
mark
red
box
paper
present
method
call
ceblast
compar
antigen
similar
protein
antigen
method
interest
novel
involv
spinimag
shell
structur
model
paper
gener
well
written
key
issu
evalu
ceblast
perform
one
evalu
conduct
use
sequenc
similar
variabl
v
region
correspond
antibodi
measur
antigen
similar
epitop
word
known
epitop
assay
selfevid
sequenc
similar
variabl
region
well
correl
antigen
similar
respect
epitop
realli
need
establishedinde
must
mani
contrari
exampl
eg
singl
mutat
lead
antigen
escap
noncontact
residu
variabl
region
neglig
impact
antigen
substitut
differ
antibodi
bind
moreorless
epitop
use
differ
bind
mode
potenti
complic
need
address
well
implic
robust
valid
thank
rais
question
realli
worth
examin
whether
vregion
similar
antibodi
may
correl
antigen
similar
respect
epitop
assay
avail
ad
result
part
revis
manuscript
page
check
qualif
measur
antigen
similar
sequenc
similar
variabl
v
region
antibodi
examin
correl
varianc
epitop
composit
lysozym
chosen
exampl
test
sinc
largest
protein
famili
dataset
total
lysozymeantibodi
complex
pdb
size
lysozym
epitop
averag
pearson
correl
coeffici
epitop
composit
differ
vregion
similar
correspond
antibodi
reach
ident
literatur
record
antibodi
deriv
differ
immun
host
mice
complex
camelu
complex
homo
sapien
complex
other
consid
vsequenc
bia
differ
immun
host
take
complex
mice
examin
correl
epitop
composit
differ
vregion
sequenc
similar
increas
antibodi
posit
similar
antibodi
ident
similar
shown
supplementari
figur
high
correl
suggest
feasibl
use
vregion
sequenc
similar
antibodi
measur
antigen
similar
howev
also
note
conform
epitop
lysozym
may
induc
quit
differ
vregion
antibodi
differ
immun
host
instanc
sequenc
identifi
score
vregion
human
antibodi
mice
antibodi
lysozym
epitop
seem
indic
meaning
adopt
vregion
sequenc
similar
antibodi
measur
antigen
similar
case
immun
host
red
scatter
diagram
repres
vregion
similar
posit
blue
scatter
diagram
repres
vregion
similar
ident
second
evalu
ceblast
undertaken
use
hi
assay
data
influenza
case
assay
epitop
told
ceblast
achiev
high
auc
valu
base
antigen
site
overlap
liao
work
smith
work
site
known
predict
escap
good
degre
accuraci
least
legaci
data
context
one
possibl
object
ceblast
accur
achiev
take
account
small
set
critic
residu
ad
valu
method
address
question
reason
first
ceblast
design
type
protein
antigen
influenza
valid
hi
assay
data
influenza
meant
test
generaliz
applic
scope
context
influenza
huge
accumul
histor
data
deriv
small
set
critic
residu
variou
predict
method
certain
degre
accuraci
howev
number
report
point
critic
posit
actual
evolv
time
ha
antigen
antigen
variant
caus
new
mutat
predefin
critic
posit
may
detect
tradit
sitedepend
method
ceblast
train
data
requir
critic
posit
use
anchor
scan
whole
structur
ha
protein
mutat
whole
sequenc
calcul
antigen
contribut
last
compar
perform
ceblast
intuit
method
similar
score
antigen
site
similar
score
strain
pair
claim
algorithm
predict
antigen
influenza
greatli
reduc
experiment
workload
facilit
vaccin
develop
need
supportif
author
know
specif
exampl
cite
awar
work
cite
actual
use
experimentalistscertainli
lead
groupsand
would
interest
see
evid
contrari
thank
point
modifi
statement
introduct
part
revis
manuscript
follow
page
algorithm
explor
assist
influenza
surveil
potenti
vaccin
strain
recommend
paper
say
antigen
without
epitop
inform
suggest
model
structur
deriv
epitop
residu
experiment
comput
conform
bcell
epitop
predict
absenc
antibodi
extrem
challeng
arguabl
wellpos
problem
see
exampl
ponomarenko
bourn
bmc
structur
biolog
independ
evalu
method
almost
invari
perform
poorli
appear
mismatch
approach
propos
term
detect
subtl
antigen
variat
author
need
clarifi
achiev
structur
defin
epitop
work
fulli
agre
opinion
sentenc
modifi
result
part
page
guarante
accuraci
ceblast
user
encourag
use
well
determin
antigen
site
antigen
without
epitop
inform
avail
bcell
epitop
predict
method
may
explor
consensu
site
test
ceblast
paper
say
ceblast
first
valid
nonredund
known
conform
epitop
term
nonredund
need
clarifi
mean
nonident
term
particip
residu
type
nonident
term
epitop
paratop
contact
someth
els
thank
point
clarifi
term
method
part
follow
page
redund
epitop
identifi
residu
composit
epitop
sequenc
correspond
antibodi
ident
review
remark
author
qiu
et
al
submit
revis
version
base
earlier
suggest
comment
rais
last
review
address
still
major
comment
manuscript
still
convinc
method
use
quantifi
influenza
antigen
author
agre
predict
structur
would
accur
enough
measur
antigen
chang
singl
mutat
epitop
howev
could
lead
antigen
drift
influenza
viru
result
antigen
analys
virus
past
four
decad
figur
seem
correct
first
antigen
drift
event
mark
correctli
exampl
figur
miss
import
antigen
drift
event
second
reemerg
virus
detect
third
clear
antigen
distanc
associ
serolog
assay
difficult
believ
use
method
data
use
analys
mani
nois
tabl
list
supplementari
file
hi
data
process
differ
protocol
exampl
hi
data
process
use
turkey
red
blood
cell
use
guinea
pig
red
blood
cell
hi
data
process
addit
neuraminidas
inhibitor
author
simpli
use
mean
titer
analys
overal
current
analys
still
crude
believ
still
convinc
method
use
quantifi
influenza
antigen
author
agre
predict
structur
would
accur
enough
measur
antigen
chang
singl
mutat
epitop
howev
could
lead
antigen
drift
influenza
viru
understood
concern
analysi
notic
substanti
conform
chang
protein
antigen
consider
influenc
antigen
predict
probabl
structur
exposur
differ
epitop
area
ceblast
work
better
antigen
rel
stabl
structur
welldefin
epitop
area
ad
part
discuss
section
page
follow
accord
algorithm
reason
ceblast
may
detect
antigen
chang
caus
singl
mutat
epitop
cover
least
aspect
residu
layout
differ
record
spinimag
neighbor
residu
around
mutat
microenvironment
chang
caus
point
mutat
detect
shell
physicalchem
fingerprint
neighbor
residu
substanti
penalti
deduct
similar
score
residu
comparison
brief
residu
layout
physicchem
chang
caus
singl
mutat
record
differ
angl
neighbor
residu
coupl
penalti
blosum
matrix
sensit
measur
antigen
chang
singl
mutat
larg
increas
ceblast
result
antigen
analys
virus
past
four
decad
figur
seem
correct
first
antigen
drift
event
mark
correctli
exampl
figur
miss
import
antigen
drift
event
second
reemerg
virus
detect
thank
point
figur
figur
gener
base
overal
result
pair
repres
strain
spot
year
actual
illustr
antigen
distanc
major
popul
either
repres
strain
previou
cluster
initi
year
new
cluster
current
cluster
initi
instead
individu
strain
pair
figur
new
cluster
defin
proport
escap
strain
rise
strain
popul
current
year
thu
antigen
drift
strain
pair
shown
figur
regard
concern
feel
also
bewild
drift
case
sinc
opposit
evid
found
cdc
report
obtain
experiment
result
cdc
report
figur
tabl
accord
formula
tabl
respons
shown
similarli
transform
experiment
data
dab
distanc
found
highli
contradictori
conclus
shown
tablerespons
nt
use
case
evalu
ceblast
howev
drift
strain
concern
highli
import
check
pair
distanc
strain
make
result
distanc
profil
accord
time
window
year
fiveyear
overlap
shown
figurerespons
subgraph
antigen
distanc
pair
strain
within
year
plot
map
classic
method
ordin
multidimension
scale
md
strain
far
away
main
cluster
would
normal
view
drift
strain
take
figurerespons
exampl
easi
notic
drift
far
away
main
cluster
two
strain
report
reassort
influenza
virus
pig
similarli
subgraph
attach
antigen
drift
strain
experiment
evid
mark
red
circl
subgraph
found
strain
signific
antigen
drift
other
detect
ad
part
result
section
page
follow
antigen
drift
event
also
scan
check
predict
antigen
distanc
strain
pair
predict
result
map
distanc
profil
accord
time
window
year
fiveyear
overlap
classic
method
ordin
multidimension
scale
md
strain
far
away
main
cluster
would
normal
view
drift
strain
shown
supplementari
figur
found
antigen
drift
strain
experiment
evid
detect
third
clear
antigen
distanc
associ
serolog
assay
difficult
believ
use
method
mayb
nt
make
clear
biologist
valu
cebalst
score
directli
associ
serolog
valu
sequenc
blast
tool
wide
accept
compar
level
similarityident
score
indic
gene
function
similar
score
ceblast
play
pretti
much
role
sequenc
blast
score
design
infer
antigen
similar
hope
help
understand
better
data
use
analys
mani
nois
tabl
list
supplementari
file
hi
data
process
differ
protocol
exampl
hi
data
process
use
turkey
red
blood
cell
use
guinea
pig
red
blood
cell
hi
data
process
addit
neuraminidas
inhibitor
author
simpli
use
mean
titer
analys
overal
current
analys
still
crude
believ
term
titer
valu
hi
data
inde
noisi
process
differ
protocol
differ
platform
consid
classif
antigen
similar
drift
actual
indic
noisi
tilter
valu
look
instanc
transform
titer
valu
similar
drift
accord
experiment
dab
cutoff
strain
pair
pair
show
contradict
result
dataset
pleas
take
classif
result
valid
model
instead
simpl
titer
valu
averag
titer
valu
affect
classif
result
pair
concern
reason
delet
noisi
pair
clean
dataset
auc
valu
rise
result
show
sera
titer
thu
result
suggest
like
design
strain
would
expect
similar
immun
strain
summari
broad
protect
spectrum
convinc
case
con
use
illustr
use
ceblast
predict
antigen
rather
find
broadspectrum
vaccin
histor
data
con
sequenc
consensu
pattern
deriv
sequenc
consensu
deriv
multipl
sequenc
align
group
sequenc
includ
possibl
see
consensu
ident
one
repres
sequenc
within
group
howev
unlik
influenc
predict
result
model
predict
antigen
distanc
topolog
similar
among
differ
strain
review
rais
interest
altern
possibl
test
model
unfortun
bind
data
publish
addit
predict
protect
spectrum
figur
show
con
cover
histor
strain
mostli
year
year
may
test
futur
experi
addit
valid
use
influenza
invit
comparison
exist
influenzabas
method
review
convinc
repres
advanc
alreadi
demonstr
gener
method
review
recommend
valid
use
second
pathogen
thank
suggest
ad
new
paragraph
predict
dengu
viru
confirm
experiment
antisera
result
result
section
page
test
gener
method
search
literatur
second
pathogen
complet
pdb
structur
antigen
welldefin
epitop
area
largescal
experiment
data
serum
titer
monoab
bind
end
antisera
data
dengu
viru
denv
largescal
studi
african
green
monkey
collect
leah
lab
valid
algorithm
leah
experi
titer
provid
sera
sampl
deriv
monkey
inject
correspond
vaccin
strain
test
strain
four
differ
denv
serotyp
remov
uninterpret
data
includ
undon
selfreact
titer
remain
data
strain
pair
includ
valid
set
envelop
e
sequenc
retriev
accord
genbank
id
provid
paper
antigen
site
collect
pitcher
report
final
structur
model
ceblast
analysi
follow
guidelin
method
note
titer
valu
influenza
case
transform
ab
ab
wide
accept
threshold
antigen
drift
threshold
retriev
denv
case
accord
experiment
result
selfreact
titer
valu
circumst
three
differ
valu
tent
chosen
classif
threshold
test
accordingli
classif
result
ceblast
achiev
auc
valu
respect
data
secondli
experiment
antigen
denv
strain
map
figur
b
md
method
data
clean
normal
see
onlin
method
section
overal
antigen
distanc
show
serotyp
closest
serotyp
wherea
serotyp
furthest
other
topolog
antigen
cluster
strain
next
examin
illustr
figur
accord
ceblast
score
four
serotyp
denv
predict
cluster
respect
ceblast
meanwhil
result
show
serotyp
firstli
cluster
serotyp
follow
serotyp
fulli
match
antigen
map
experiment
titer
accomplish
md
figur
within
individu
serotyp
group
ceblast
result
also
agre
well
experiment
result
take
serotyp
exampl
strain
figur
firstli
cluster
follow
other
topolog
structur
indic
antigen
closest
secondli
interestingli
leah
result
either
onemonth
threemonth
postinfect
sera
confirm
predict
titer
valu
vs
highest
among
pair
vs
test
strain
follow
secondli
high
titer
valu
indic
close
antigen
strain
cluster
accord
sequenc
similar
structur
similar
e
antigen
sequencebas
cluster
serotyp
firstli
cluster
serotyp
follow
serotyp
figur
disagre
leah
experiment
result
importantli
similar
infer
sequencebas
method
structurebas
method
cluster
tree
construct
base
rmsd
structur
comparison
result
display
figur
similar
sequenc
cluster
structur
cluster
suggest
neither
interserotyp
relationship
rel
strain
similar
within
denv
serotyp
therefor
ceblast
model
seem
give
best
infer
serolog
similar
compar
sequenceor
structurebas
method
also
ad
new
paragraph
onlin
method
section
page
gener
complet
data
antigen
map
test
strain
undon
empti
valu
line
remov
tabl
leah
studi
antisera
valu
label
arbitrarili
set
valu
simpli
calcul
test
strain
remain
antisera
valu
line
test
strain
titer
valu
normal
within
set
highest
antisera
valu
supplementari
tabl
final
antigen
map
done
ordin
multidimension
scale
md
accord
normal
titer
fundament
problem
tool
still
imposs
predict
structur
chang
caus
one
small
number
amino
acid
current
stateofart
structur
predict
algorithm
thu
result
use
model
would
accur
model
accur
antigen
variat
influenza
virus
figur
exampl
miss
key
variant
exampl
reemerg
antigen
similar
virus
middl
caus
human
case
identifi
studi
seen
valu
current
tool
incorrect
simpli
averag
hi
data
variou
sourc
author
understood
challeng
fundament
address
issu
rais
data
issu
author
must
understand
antigen
differ
much
complic
simpli
compar
serolog
titer
two
virus
author
still
state
design
potenti
broadspectrum
vaccin
fundament
issu
rais
address
review
remark
author
author
propos
new
structureand
physicochemicalpropertybas
match
tool
analog
blast
identifi
antigen
import
chang
epitop
interest
idea
would
valuabl
fast
antigen
match
sequenc
data
appropri
serolog
exist
ask
comment
earlier
review
manuscript
particular
whether
author
convincingli
demonstr
util
method
regrett
nt
find
demonstr
suffici
clearli
techniqu
may
well
extrem
effect
primari
dataset
use
sensibl
one
compris
wide
rang
influenza
sequenc
hemagglutin
inhibit
data
ideal
kind
work
find
valid
comparison
tool
less
ideal
first
author
deliber
compar
ceblast
exist
tool
reli
assay
data
train
model
believ
would
unfair
comparison
tool
tune
use
assay
data
howev
suspect
would
also
show
tool
less
effect
techniqu
ultim
goal
furthermor
tune
presum
done
base
assay
data
avail
least
chosen
beta
equat
revis
manuscript
equat
paramet
affect
chosen
rang
differ
possibl
respons
review
author
also
point
ceblast
score
directli
correspond
serolog
valu
complet
understand
kind
tool
especi
chosen
train
use
assay
data
also
detract
util
tool
instanc
tool
look
date
differ
isol
compar
assess
antigen
similar
base
number
year
separ
sampl
might
quit
well
need
offer
direct
associ
serolog
due
strong
antigen
drift
observ
though
suggest
anyth
crude
would
well
tool
comparison
assaytrain
tool
would
therefor
valuabl
understand
state
art
area
would
nt
necessari
show
tool
better
sinc
differ
target
mind
comparison
structur
align
tool
valuabl
nt
tell
whole
stori
none
realli
design
task
understand
valid
con
would
also
much
valuabl
instead
identifi
someth
unusu
similar
base
structur
physicochem
properti
immedi
predict
phylogeni
instanc
even
better
incorpor
revers
genet
demonstr
tool
could
predict
chang
antigen
phenotyp
ideal
chang
make
viru
antigen
similar
phylogenet
distant
virus
move
away
closer
virus
result
readili
identifi
structur
chang
none
necessarili
detract
overal
qualiti
algorithm
design
author
feel
demonstr
suffici
clearli
well
work
revis
version
author
list
exampl
fundament
address
concern
accuraci
use
propos
tool
fundament
problem
tool
still
imposs
predict
structur
chang
caus
one
small
number
amino
acid
current
stateofart
structur
predict
algorithm
thu
result
use
model
would
accur
model
accur
antigen
variat
influenza
virus
figur
exampl
miss
key
variant
exampl
reemerg
antigen
similar
virus
middl
caus
human
case
identifi
studi
seen
valu
current
tool
understand
concern
comput
model
ceblast
may
abl
predict
individu
variant
thu
test
model
base
massiv
histor
data
differ
date
compar
avail
comput
peer
assaytrain
influenza
viru
newli
ad
fig
result
show
assayindepend
model
perform
similarli
well
assaytrain
tool
importantli
unsupervis
method
would
valuabl
new
pathogen
appropri
serolog
exist
demonstr
intersubtyp
dengu
viru
crossviru
case
zika
dengu
incorrect
simpli
averag
hi
data
variou
sourc
author
understood
challeng
fundament
address
issu
rais
data
issu
author
must
understand
antigen
differ
much
complic
simpli
compar
serolog
titer
two
virus
version
gave
averag
hi
valu
use
classic
cutoff
dab
judg
antigen
similar
drift
pair
accord
experiment
result
pair
consist
classif
experiment
result
taken
version
test
dataset
author
still
state
design
potenti
broadspectrum
vaccin
fundament
issu
rais
address
reconstruct
version
gave
statement
took
con
new
valid
case
thu
chang
statement
reliabl
predict
new
influenza
vaccin
review
remark
author
author
propos
new
structureand
physicochemicalpropertybas
match
tool
analog
blast
identifi
antigen
import
chang
epitop
interest
idea
would
valuabl
fast
antigen
match
sequenc
data
appropri
serolog
exist
ask
comment
earlier
review
manuscript
particular
whether
author
convincingli
demonstr
util
method
regrett
nt
find
demonstr
suffici
clearli
techniqu
may
well
extrem
effect
primari
dataset
use
sensibl
one
compris
wide
rang
influenza
sequenc
hemagglutin
inhibit
data
ideal
kind
work
find
valid
comparison
tool
less
ideal
first
author
deliber
compar
ceblast
exist
tool
reli
assay
data
train
model
believ
would
unfair
comparison
tool
tune
use
assay
data
howev
suspect
would
also
show
tool
less
effect
techniqu
ultim
goal
great
thank
construct
suggest
version
made
complet
comparison
access
tool
influenza
reconstruct
manuscript
chang
titl
manuscript
ceblast
make
possibl
precis
comput
antigen
similar
newli
emerg
pathogen
made
comprehens
comparison
model
exist
assaytrain
tool
way
predict
simul
differ
train
dataset
via
slide
window
year
result
summar
figur
demonstr
method
perform
similarli
well
peer
current
test
date
earli
year
perform
assaytrain
model
vari
differ
expect
respons
concern
paragraph
ad
paper
addit
simul
predict
result
ceblast
peer
differ
train
data
size
differ
date
via
slide
window
year
train
data
continu
increas
test
continu
decreas
onlin
method
almost
avail
insilico
tool
influenza
compris
supervis
model
three
assaytrain
method
chosen
repres
peer
includ
lee
method
antigenco
recent
method
qiu
consid
repeat
access
shown
fig
overal
predict
abil
supervis
model
vari
differ
across
differ
date
auc
valu
begin
test
period
size
train
data
kept
increas
perform
becom
rel
stabl
auc
valu
comparison
ceblast
gave
high
perform
auc
valu
around
begin
maintain
consist
high
stabl
auc
valu
across
whole
test
period
unsupervis
method
promin
valu
ceblast
appear
abl
process
fast
antigen
match
new
antigen
appropri
serolog
exist
subsequ
thu
extend
predict
abil
tool
new
antigen
differ
pathogen
furthermor
tune
presum
done
base
assay
data
avail
least
chosen
beta
equat
revis
manuscript
equat
paramet
affect
chosen
rang
differ
possibl
thank
point
analyz
distribut
paramet
equat
found
distribut
environment
similar
score
residu
two
paramet
natur
number
balanc
order
magnitud
differ
paramet
beta
simpli
set
order
paramet
magnitud
reach
level
respons
review
author
also
point
ceblast
score
directli
correspond
serolog
valu
complet
understand
kind
tool
especi
chosen
train
use
assay
data
also
detract
util
tool
instanc
tool
look
date
differ
isol
compar
assess
antigen
similar
base
number
year
separ
sampl
might
quit
well
need
offer
direct
associ
serolog
due
strong
antigen
drift
observ
though
suggest
anyth
crude
would
well
tool
mayb
nt
make
clear
thank
point
although
ceblast
score
directli
correspond
serolog
valu
score
differ
strain
pair
compar
rel
furthermor
classif
antigen
similar
drift
suggest
empir
threshold
recommend
model
importantli
said
model
would
valuabl
new
pathogen
appropri
serolog
exist
comparison
assaytrain
tool
would
therefor
valuabl
understand
state
art
area
would
nt
necessari
show
tool
better
sinc
differ
target
mind
comparison
structur
align
tool
valuabl
nt
tell
whole
stori
none
realli
design
task
understand
total
agre
point
version
compar
ceblast
avail
assaytrain
tool
found
compar
good
perform
influenza
addit
highlight
util
model
new
pathogen
thank
kind
guidanc
util
prove
intersubtyp
dengu
viru
new
pathogen
zika
viru
valid
con
would
also
much
valuabl
instead
identifi
someth
unusu
similar
base
structur
physicochem
properti
immedi
predict
phylogeni
instanc
even
better
incorpor
revers
genet
demonstr
tool
could
predict
chang
antigen
phenotyp
ideal
chang
make
viru
antigen
similar
phylogenet
distant
virus
move
away
closer
virus
result
readili
identifi
structur
chang
comment
highli
enlighten
reconstruct
version
organ
valid
method
three
differ
level
intrasubtyp
influenza
viru
intersubtyp
dengu
viru
crossviru
case
dengu
zika
viru
expect
fulli
demonstr
two
new
part
ad
version
intersubtyp
case
dengu
viru
phylogenet
distant
dengu
virus
success
detect
antigen
similar
pair
neither
tradit
sequencebas
structurebas
comparison
method
infer
crossviru
case
antigen
similar
pair
suggest
also
crossreact
epitop
dengu
zika
viru
precis
delin
via
ceblast
detail
kindli
refer
two
new
valid
part
result
discuss
attach
test
gener
ceblast
toward
newli
emerg
pathogen
antisera
data
denv
collect
largescal
studi
african
green
monkey
cite
studi
sera
sampl
deriv
monkey
inject
correspond
vaccin
strain
test
individu
denv
strain
four
differ
serotyp
remov
uninterpret
data
undon
selfreact
titer
remain
titer
data
strain
pair
includ
valid
set
model
e
protein
structur
ceblast
accord
sequenc
provid
paper
unlik
influenza
empir
titer
threshold
report
abl
classifi
antigen
similar
varianc
denv
case
accord
statist
avail
data
titer
valu
selfreact
pair
thu
three
differ
valu
tent
chosen
classif
threshold
test
accordingli
classif
result
ceblast
achiev
auc
valu
respect
strain
pair
next
antigen
group
result
ceblast
compar
classic
sequenc
similar
structur
similar
base
experiment
serolog
topolog
fig
show
serolog
topolog
experiment
group
denv
strain
multidimension
scale
md
method
data
clean
normal
onlin
method
could
observ
serotyp
cluster
close
serotyp
wherea
serotyp
cluster
furthest
remaind
fig
ceblast
result
four
serotyp
denv
could
correctli
predict
cluster
comparison
group
topolog
serotyp
first
cluster
serotyp
wherea
serotyp
furthest
remain
strain
fulli
match
experiment
topolog
howev
sequencebas
cluster
fig
serotyp
first
cluster
serotyp
follow
serotyp
last
serotyp
disagre
experiment
result
neither
could
structur
method
achiev
correct
topolog
denv
subtyp
display
fig
addit
intersubtyp
denv
ceblast
also
yield
better
predict
intrasubtyp
pathogen
sequencebas
structurebas
method
take
serotyp
exampl
strain
mark
star
topolog
structur
indic
antigen
closest
secondli
predict
strongli
corrobor
experiment
result
either
onemonth
threemonth
postinfect
sera
titer
valu
vs
highest
among
pair
test
strain
follow
second
highest
titer
valu
indic
close
antigen
contrast
neither
sequencebas
structurebas
method
could
suggest
best
serolog
relationship
within
denv
subtyp
display
fig
therefor
ceblast
model
appear
give
best
infer
serolog
similar
denv
subtyp
compar
classic
sequenceor
structurebas
method
obtain
result
indict
uniqu
abil
ceblast
predict
antigen
similar
intraand
intersubtyp
new
pathogen
next
ceblast
test
across
differ
virus
detect
potenti
crossreact
latest
aris
pathogen
zikv
avail
pathogen
denv
zikv
member
flaviviru
famili
recent
emerg
brazil
quickli
becam
signific
public
health
concern
evid
show
zikv
infect
may
lead
neurolog
complic
syndrom
adult
micocephali
newborn
sever
report
discov
antibodi
isol
patient
dengu
potenti
crossreact
zikv
main
target
neutral
antibodi
e
protein
report
share
high
structur
similar
rootmeansquar
deviat
rmsd
overal
sequenc
ident
zikv
denv
predict
potenti
crossreact
epitop
zikv
differ
denv
subtyp
four
repres
e
protein
randomli
sampl
dataset
denv
subtyp
well
zikv
conveni
comput
screen
round
patch
collect
residu
protein
surfac
structur
model
e
monom
dimer
respect
onlin
method
surfac
patch
zikv
compar
correspond
patch
denv
subtyp
ceblast
potenti
crossreact
patch
crp
mark
similar
score
rose
certain
threshold
frequenc
crp
label
center
residu
map
onto
heat
map
result
binari
comparison
zikv
denv
structur
shown
fig
differ
row
repres
denv
subtyp
addit
result
found
supplementari
fig
although
insilico
crossreact
frequenc
could
vari
among
differ
subtyp
denv
strongli
consist
crp
domain
ii
addit
weak
crp
domain
could
detect
across
denv
subtyp
fig
predict
support
experiment
result
studi
stettler
et
al
test
reactiv
abil
domain
iii
domain
iii
e
protein
monom
note
true
epitop
often
irregularli
shape
wherea
circular
surfac
patch
artifici
oversimplifi
conveni
screen
purpos
cre
residu
may
contain
differ
artifici
patch
particular
artifici
patch
cover
suffici
cre
residu
like
constitut
crp
thu
overlap
crp
like
indic
locat
true
epitop
subsequ
individu
residu
insilico
crp
given
subtyp
first
map
onto
surfac
e
antigen
concentr
area
averag
shown
green
fig
hint
potenti
crossreact
epitop
cre
zika
denv
subtyp
respect
subsequ
overlap
subtyp
cre
suggest
green
region
fig
potenti
cre
across
denv
subtyp
zikv
viru
similar
strategi
appli
e
protein
dimer
structur
comput
cre
across
denv
subtyp
strongli
hint
domain
ii
albeit
slightli
domain
iii
opposit
chain
dimer
structur
supplementari
fig
whole
cre
predict
e
dimer
involv
surfac
residu
label
fig
notabl
comput
cre
highli
overlap
result
crystal
work
immunecomplex
barbaspaeth
et
al
particular
comput
cra
residu
locat
bind
interfac
deriv
structur
complex
antibodi
e
protein
dimer
fig
import
residu
suggest
barbaspaeth
et
al
includ
predict
fig
